BIOMERICA INC. - COMM
0.3740
08-November-24 12:20:04
15 minutes delayed
Stocks
-0.0048
-1.27%
Today's range
0.3530 - 0.4011
ISIN
N/A
Source
NASDAQ
-
Diagnostics Industry Leader Jack Kenny Joins Biomerica’s Board of Directors
28 Aug 2023 08:19:00 By Nasdaq GlobeNewswire
-
Biomerica Reports Fiscal 2023 Year End Results
25 Aug 2023 17:00:00 By Nasdaq GlobeNewswire
-
03 Aug 2023 08:19:00 By Nasdaq GlobeNewswire
-
inFoods® IBS Test Now Validated for Use with Simple Finger Stick Whole Blood Collection Technology
18 May 2023 08:19:00 By Nasdaq GlobeNewswire
-
17 Apr 2023 07:47:00 By Nasdaq GlobeNewswire
-
Biomerica Reports Q3 Fiscal 2023 Results
14 Apr 2023 16:48:29 By Nasdaq GlobeNewswire
-
08 Mar 2023 08:19:00 By Nasdaq GlobeNewswire
-
Biomerica Announces Closing of $8 Million Underwritten Public Offering of Common Stock
07 Mar 2023 16:39:57 By Nasdaq GlobeNewswire
-
Biomerica Announces Pricing of $8 Million Underwritten Public Offering of Common Stock
03 Mar 2023 07:30:00 By Nasdaq GlobeNewswire
-
Biomerica Announces Proposed Underwritten Public Offering of Common Stock
02 Mar 2023 17:15:01 By Nasdaq GlobeNewswire
-
Biomerica Reports Financial Results for Fiscal 2023 Second Quarter Ended November 30, 2022
13 Jan 2023 18:39:00 By Nasdaq GlobeNewswire
-
10 Jan 2023 08:19:00 By Nasdaq GlobeNewswire
-
08 Dec 2022 08:19:00 By Nasdaq GlobeNewswire
-
02 Nov 2022 08:19:00 By Nasdaq GlobeNewswire
-
14 Oct 2022 09:18:00 By Nasdaq GlobeNewswire
-
Biomerica Reports 30% Increase in Revenues for Fiscal Q1 2023 vs. Fiscal Q1 2022
13 Oct 2022 16:50:00 By Nasdaq GlobeNewswire
-
29 Sep 2022 08:19:00 By Nasdaq GlobeNewswire
-
Biomerica Plans Launch of InFoods® IBS Test; Names Robert Carlson as Chief Commercial Officer
30 Aug 2022 08:19:00 By Nasdaq GlobeNewswire
-
Biomerica Reports Fiscal 2022 Year End Results
29 Aug 2022 16:41:00 By Nasdaq GlobeNewswire